Single-Cell Sequencing Market Global Analysis, Statistics And Revenue Research Report by 2027

Single-Cell Sequencing Market

Growing usage of single-cell sequencing in oncology is one of the significant factors influencing the market growth.

According to a recent analysis by Emergen Research, the worldwide single-cell sequencing market is anticipated to reach USD 3,230.6 Million by 2027. Single-cell sequencing is frequently used to resolve tumour heterogeneity, rebuild the evolutionary paths taken by cancer cells, and identify unusual sub-clones, making it a promising method for addressing treatment resistance. Single-cell sequencing has recently been used by researchers at the University of South California (USC) to detect sub-clones in cancer tissue. These findings could offer crucial scientific insights into how cancer develops, spreads, and develops resistance to treatment.

Increased R&D spending by single-cell sequencing sector companies is essential for fueling the market’s expansion. In the third quarter of 2019 compared to the same period in 2018, 10X Genomics’ R&D spending increased to USD 22.2 million, driven by increased funding for workforce hiring, infrastructure development, and supplies. 10X Genomics is a leading biotech company that designs and manufactures technology for genome sequencing.

Claim Your FREE Sample Copy with Table of [email protected]

The requirement to uphold high standards (the use of pricey, high-grade materials) and adhere to regulatory authorities’ directives drives up the price of single-cell biology research. Budget restrictions make it challenging for academic and research labs to purchase such pricey equipment. The total cost of ownership of these instruments has increased as a result of the maintenance charges as well as a number of other indirect expenses. This is a significant obstacle to the widespread use of flow cytometers and microfluidic devices in both clinical and academic settings.

Key Highlights from the Report

  • In 2019, single-cell isolation accounted for a sizeable portion of the market due to its capacity to help achieve cell viability of 99.0% without interfering with whole genome amplification, polymerase chain reaction (PCR), or whole transcriptome amplification (WTA) operations.
  • Numerous businesses and investors in a variety of industries, including fundamental research, drug discovery and production, reproductive and consumer genomics, have expressed interest in the next-generation sequencing (NGS) technology.
  • Due to the creation and application of cutting-edge tools and solutions in the management of numerous chronic and infectious diseases, instruments held a greater market share in terms of revenue in 2019.

Key participants include Illumina, Thermo Fisher Scientific Inc., Fludigim, Bio-Rad, Becton, Dickinson, and Company, Qiagen, F Hoffmann-La Roche Ltd., BGI, 10X Genomics Inc., Oxford Nanopore Technologies, among others.

Emergen Research has segmented the global single-cell sequencing market on the basis of product type, workflow, technology, disease type, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2017-2027)

  • Reagents
  • Instruments

Workflow Outlook (Revenue, USD Billion; 2017-2027)

  • Single Cell Isolation
  • Sample Preparation
  • Genomic Sequencing

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Sequencing
  • qPCR
  • Microarray
  • MDA
  • PCR

Disease Type Outlook (Revenue, USD Billion; 2017-2027)

  • Oncology
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Subpopulation Characterization
  • Genomic Variation
  • Others

End Use Outlook (Revenue, USD Billion; 2017-2027)

  • Academic & Research Laboratories
  • Hospitals & Clinics
  • Biopharmaceutical & Biotechnology Companies
  • Others

For More Details On this [email protected]

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    1. U.S.
    2. Canada
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkedIn | Twitter | Blogs

Latest Reports: Aerospace 3D Printing Market, Military Robots Market

Trending Reports: Medical Device Security Market, Pectin Market

You may also like...

Leave a Reply

Your email address will not be published.